CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN) dated as of October 4, 2016 by and among OXFORD IMMUNOTEC, INC., as Borrower, OXFORD IMMUNOTEC GLOBAL PLC and OXFORD IMMUNOTEC LIMITED, as guarantors, the other Credit Parties party from time to...Credit, Security and Guaranty Agreement • October 7th, 2016 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 7th, 2016 Company Industry JurisdictionTHIS CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN) (as the same may be amended, supplemented, restated or otherwise modified from time to time, the “Agreement”) is dated as of October 4, 2016 by and among Oxford immunotec, inc., a Delaware corporation, and any additional borrower that may hereafter be added to this Agreement (individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted assigns, the “Borrowers”), OXFORD IMMUNOTEC GLOBAL PLC, a company formed under the laws of England and Wales (“Oxford Global”), OXFORD IMMUNOTEC LIMITED, a company formed under the laws of England and Wales (“Oxford Limited” and together with Oxford Global and any other entities that become party hereto as a Guarantor and each of their successors and permitted assigns, individually as a “Guarantor” and collectively, as the “Guarantors”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, individually as a Lend
CREDIT, SECURITY AND GUARANTY AGREEMENT (TERM LOAN) dated as of October 4, 2016 by and among OXFORD IMMUNOTEC, INC., as Borrower, OXFORD IMMUNOTEC GLOBAL PLC and OXFORD IMMUNOTEC LIMITED, as guarantors, the other Credit Parties party from time to time...Credit, Security and Guaranty Agreement (Term Loan) • October 7th, 2016 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 7th, 2016 Company Industry JurisdictionTHIS CREDIT, SECURITY AND GUARANTY AGREEMENT (TERM LOAN) (as the same may be amended, supplemented, restated or otherwise modified from time to time, the “Agreement”) is dated as of October 4, 2016 by and among Oxford immunotec, inc., a Delaware corporation, and any additional borrower that may hereafter be added to this Agreement (individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted assigns, the “Borrowers”), OXFORD IMMUNOTEC GLOBAL PLC, a company formed under the laws of England and Wales (“Oxford Global”), OXFORD IMMUNOTEC LIMITED, a company formed under the laws of England and Wales (“Oxford Limited” and together with Oxford Global and any other entities that become party hereto as a Guarantor and each of their successors and permitted assigns, individually as a “Guarantor” and collectively, as the “Guarantors”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, individually as a Lender, a